HIV-VAC (HIVV on OTC Bulletin Board) is a penny stock with very high potential. The Company makes AIDS vaccines with is a very high potential market. The HIV-VAC vaccine is currently undergoing pre-clinical trials at the Russia AIDS Center, Moscow and is expected to start a phase I/II clinical trial in Moscow in the winter of 2001. The CEO of the company is buying a lot of stocks in the company. HIV-VAC is one off the cheapest stocks in on the market with so many potential (but a high risk). A few days ago the stock gained more then 350% but now the stock is back on its bottom. And perhaps ready to go!!!
The stock is a high risk but it can go make gains from more the 600% There are rumours that the company soon introduce new products against AIDS!! It has a currently stock price: $0.13 (52 week high $11). Its a gamble, but a very smart one (I think)!!